The US Food and Drug Administration (FDA) on Friday approved Arcutis Biotherapeutics’ drug for treating a skin condition called seborrheic…
Trending
- US Publication Hails Pakistan’s “Macroeconomic Miracle,” Attracting Global Investor Attention
- Pakistan’s Pharmaceutical Retail Booms, But Growth Driven by Price Hikes
- Pakistan’s Budget 2025-26 Faces Significant External Debt Repayment Surge
- Market Bulls Charge: KSE-100 Hits Record High Amidst Growing Investor Confidence
- ECC Decision: Fuel Price Relief Diverted from Consumers to Refineries and Dealers
- China’s Humanoid Robot Push: Factories Staffed by Machines in Ambitious Plan
- Microsoft Announces Major Restructuring, Cutting Approximately 6,000 Jobs Globally
- WhatsApp Developing Optional Feature for Resharing Status Updates